文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Neurotoxicity, Neuroprotection, In Vitro MAOA/MAOB Inhibitory Activity Assessment, Molecular Docking, and Permeability Assay Studies of Newly Synthesized Hydrazones Containing a Pyrrole Ring.

作者信息

Georgieva Maya, Mateev Emilio, Valkova Iva, Kuteva Hristina, Tzankova Diana, Stefanova Denitsa, Yordanov Yordan, Lybomirova Karolina, Zlatkov Alexander, Tzankova Virginia, Kondeva-Burdina Magdalena

机构信息

Department Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.

Department Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.

出版信息

Molecules. 2024 Sep 12;29(18):4338. doi: 10.3390/molecules29184338.


DOI:10.3390/molecules29184338
PMID:39339333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11433870/
Abstract

Neurodegenerative diseases such as Parkinson's and Alzheimer's continue to be some of the most significant challenges in modern medicine. Recent research related to the molecular mechanisms of parkinsonism has opened up new approaches to antiparkinsonian therapy. In response to this, we present the evaluation of the potential neuroprotective and MAOA/MAOB inhibitory effects of newly synthesized hydrazones, containing a pyrrole moiety in the carboxyl fragment of the structure. The substances were studied on different brain subcellular fractions, including rat brain synaptosomes, mitochondria, and microsomes. The single application of 50 µM of each compound to the subcellular fractions showed that all substances exhibit a weak neurotoxic effect, with , , and being the least neurotoxic representatives. The corresponding neuroprotective and antioxidant effects were also evaluated in different injury models on subcellular fractions, single out , , and as the most prominent derivatives. A 1 µM concentration of each molecule from the series was also studied for potential MAOA/MAOB inhibitory effects. The results revealed a lack of MAOA activity for all evaluated structures and the appearance of MAOB effects, with compounds , , and showing effects similar to those of selegiline. The best MAOB selectivity index (>204) was determined for and , distinguishing these two representatives as the most promising molecules for further studies as potential selective MAOB inhibitors. The performed molecular docking simulations defined the appearance of selective MAOB inhibitory effects based on the interaction of the tested molecules with Tyr398, which is one of the components of the aromatic cage of MAOB and participated in π-π stabilization with the aromatic pyrrole ring. The preliminary PAMPA testing indicated that in relation to the blood-brain barrier (BBB) permeability, the tested pyrrole-based hydrazones may be considered as high permeable, except for and , which were established to be permeable in the medium range with -logP of 5.268 and 5.714, respectively, compared to the applied references.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/0bdeb2d61d19/molecules-29-04338-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/5ee17b18e655/molecules-29-04338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/6c655dc5e127/molecules-29-04338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/3ebbbb5dae5d/molecules-29-04338-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/0b3ef87d535d/molecules-29-04338-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/5e042b86f30a/molecules-29-04338-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/36fdf9a1b094/molecules-29-04338-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/58cd7d5d1aa5/molecules-29-04338-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/d88fe79493a5/molecules-29-04338-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/a51cbf50e98f/molecules-29-04338-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/c95397f17933/molecules-29-04338-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/135537129c43/molecules-29-04338-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/ecc4230433d5/molecules-29-04338-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/c49ed0d169f7/molecules-29-04338-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/0bdeb2d61d19/molecules-29-04338-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/5ee17b18e655/molecules-29-04338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/6c655dc5e127/molecules-29-04338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/3ebbbb5dae5d/molecules-29-04338-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/0b3ef87d535d/molecules-29-04338-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/5e042b86f30a/molecules-29-04338-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/36fdf9a1b094/molecules-29-04338-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/58cd7d5d1aa5/molecules-29-04338-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/d88fe79493a5/molecules-29-04338-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/a51cbf50e98f/molecules-29-04338-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/c95397f17933/molecules-29-04338-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/135537129c43/molecules-29-04338-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/ecc4230433d5/molecules-29-04338-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/c49ed0d169f7/molecules-29-04338-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c415/11433870/0bdeb2d61d19/molecules-29-04338-g014.jpg

相似文献

[1]
Neurotoxicity, Neuroprotection, In Vitro MAOA/MAOB Inhibitory Activity Assessment, Molecular Docking, and Permeability Assay Studies of Newly Synthesized Hydrazones Containing a Pyrrole Ring.

Molecules. 2024-9-12

[2]
In Silico Evaluation and In Vitro Determination of Neuroprotective and MAO-B Inhibitory Effects of Pyrrole-Based Hydrazones: A Therapeutic Approach to Parkinson's Disease.

Molecules. 2022-12-2

[3]
Design, Synthesis and Evaluation of 8-Thiosubstituted 1,3,7- Trimethylxanthine Hydrazones with In-vitro Neuroprotective and MAO-B Inhibitory Activities.

Med Chem. 2020

[4]
Design, Synthesis, and Evaluation of 2-Amino-6-nitrobenzothiazole-Derived Hydrazones as MAO Inhibitors: Role of the Methylene Spacer Group.

ChemMedChem. 2016-7-19

[5]
Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration.

Bioorg Med Chem. 2023-9-7

[6]
Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.

Bioorg Med Chem Lett. 2014-8-1

[7]
Synthesis of New Hydrazone Derivatives for MAO Enzymes Inhibitory Activity.

Molecules. 2017-8-20

[8]
New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.

Comb Chem High Throughput Screen. 2017

[9]
Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.

Bioorg Chem. 2021-11

[10]
Design, synthesis, in-vitro, in-vivo and ex-vivo pharmacology of thiazolidine-2,4-dione derivatives as selective and reversible monoamine oxidase-B inhibitors.

Bioorg Med Chem Lett. 2022-11-15

引用本文的文献

[1]
Classical Paal-Knorr Cyclization for Synthesis of Pyrrole-Based Aryl Hydrazones and In Vitro/In Vivo Evaluation on Pharmacological Models of Parkinson's Disease.

Molecules. 2025-7-28

本文引用的文献

[1]
Development of a mouse model expressing a bifunctional glutathione-synthesizing enzyme to study glutathione limitation in vivo.

J Biol Chem. 2024-2

[2]
Synthesis, DFT Study, and In Vitro Evaluation of Antioxidant Properties and Cytotoxic and Cytoprotective Effects of New Hydrazones on SH-SY5Y Neuroblastoma Cell Lines.

Pharmaceuticals (Basel). 2023-8-23

[3]
In Silico Evaluation and In Vitro Determination of Neuroprotective and MAO-B Inhibitory Effects of Pyrrole-Based Hydrazones: A Therapeutic Approach to Parkinson's Disease.

Molecules. 2022-12-2

[4]
Intracellular GSH/GST antioxidants system change as an earlier biomarker for toxicity evaluation of iron oxide nanoparticles.

NanoImpact. 2021-7

[5]
Revisiting the Role of Astrocytic MAOB in Parkinson's Disease.

Int J Mol Sci. 2022-4-18

[6]
Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future.

J Parkinsons Dis. 2022

[7]
A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.

Eur J Med Chem. 2020-11-15

[8]
Expeditious and eco-friendly synthesis of new multifunctionalized pyrrole derivatives and evaluation of their antioxidant property.

Bioorg Chem. 2020-5

[9]
Computational Study of -Substituent Effects on Antioxidant Activities of Phenolic Dendritic Antioxidants.

Antioxidants (Basel). 2020-2-25

[10]
The conformational dynamics of wing gates Ile199 and Phe103 on the binding of dopamine and benzylamine substrates in human monoamine Oxidase B.

J Biomol Struct Dyn. 2021-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索